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Abstract 
The acceleration of nanomaterials research has brought about increased demands for rapid 
analysis of their bioactivity, in a multi-parametric fashion, to minimise the gap between 
potential applications and knowledge of their toxicological properties. The potential of Raman 
microspectroscopy for the analysis of biological systems with the aid of multivariate analysis 
techniques has been demonstrated. In this study, an overview of recent efforts towards 
establishing a ‘label-free high content nanotoxicological assessment technique’ using Raman 
microspectroscopy is presented. The current state of the art for cellular toxicity assessment and 
the potential of Raman microspectroscopy are discussed, and the spectral markers of the 
cellular toxic responses upon exposure to nanoparticles, changes on the identified spectral 
markers upon exposure to different nanoparticles, cell death mechanisms and the effects of 
nanoparticles on different cell lines are summarised. Moreover, 3D toxicity plots of spectral 
markers, as a function of time and dose, are introduced as new methodology for toxicological 
analysis based on the intrinsic properties of the biomolecular changes, such as cytoplasmic 
RNA aberrations, protein and lipid damage associated with the toxic response. The 3D 
evolution of the spectral markers are correlated with the results obtained by commonly-used 
cytotoxicity assays and significant similarities are observed between band intensity and 
percentage viability obtained by the Alamar Blue assay, as an example. Therefore, the 
developed 3D plots can be used to identify toxicological properties of a nanomaterial and can 
potentially be used to predict toxicity which can provide rapid advances in nanomedicine. 
Keywords: Nanotoxicology, cytotoxicity, genotoxicity, Raman microspectroscopy, high 
content analysis, spectral markers 
1. Introduction: Nanotoxicology 
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The increasing interest in, and accelerated research on, naturally occurring or engineered 
nanomaterials, due to their possible impacts on society in terms of science and technological 
advancements, has raised questions regarding their health and environmental impact and led to 
the development of ‘Nanotoxicology’ as a new branch of toxicology to guide the safe 
deployment and suitable production of these novel materials [1-3].  
Materials of nanoscale dimensions have been identified as possessing extraordinary and 
sometimes unique physicochemical and optical properties [4-6], which make them invaluable 
for a wide range of fields such as materials science [7], aerospace [8], cosmetics [9], medicine 
[10] and the pharmaceutical industry [11], to improve structures and to contribute to the 
development of new treatment strategies and early diagnosis of many diseases [12-16]. On the 
other hand, these properties have also been observed to facilitate their interaction with 
biological systems, which necessitates their responsible use and rapid toxicological analysis to 
predict possible adverse consequences [1, 17]. Health organisations have already established 
plans to promote on-going research in nanoscience as well as nanotoxicology [18, 19]. The 
Organisation for Economic Co-operation and Development (OECD) has published a list of 
nanomaterials with high-economic interest which require immediate investigation in terms of 
Health and Environmental impact [19, 20]. The European Union (EU) has established the 
‘NanoSafety Cluster’, which is a consortium of sponsored projects related to toxicology, 
exposure assessment, mechanism of interaction and risk assessment of nanomaterials in order 
to maximising the synergy between European level projects [21]. 
2. Current Approaches for Toxicological Assessment of Nanomaterial Toxicity 
Most of the strategies that have been proposed for the investigation of nanomaterials include 
the combinational use of toxicity assays, bio-imaging techniques, chemical and biochemical 
assays, to obtain information regarding to metabolic activity, membrane integrities, cellular 
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viability and cell death mechanisms upon exposure. Cytotoxicity assays have been widely 
employed to determine cellular viability and also cell death rate in vitro. For example, the 
tetrazolium salts, such as MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide), MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium), XTT (,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-
tetrazolium-5-carboxanilide) and WST-1 (2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-
(2,4-disulfophenyl)-2H-tetrazolium) (soluble versions of MTT) assays, have been used to 
determine cellular viability based on the energy-state of the cell [22, 23]. The Alamar Blue 
assay (AB), which provides information regarding to overall cell health and proliferative 
capacity, has also been widely used for determination of nanoparticle toxicity [23-25]. The 
lactate Dehydrogenase (LDH) [26] and trypan blue [27] assays have been employed to 
determine cell membrane integrity and cell death rates. For long term toxicity, the clonogenic 
assay has been employed to determine colony forming efficiency and decreased or increased 
survival [28, 29]. Assays such as mitochondrial membrane potential, cellular protonation and 
reactive oxygen species production have been used to elucidate mechanisms of action of 
nanomaterials in cells. Assays which measure the activation of caspases, release of 
inflammatory factors and activation of pro-apoptotic bcl-2 proteins provide further information 
regarding acute toxic effects of nanomaterials inside the cells. Electron microscopy (EM) and 
optical microscopy have been used for the visualisation of nanomaterials in cells. Confocal 
Microscopy (CLSM) has also been used for the visualisation of nanomaterials in cells with the 
aid of fluorescent labels [30-33]. High Content Analysis/Screening (HCA/HCS), has opened 
up new perspectivesfor toxicological assesment by providing multifaceted information with 
high sensitivity based on automated imaging of ‘phenotypic assay endpoints’. The technique 
has been used for in vitro toxicity assesment, animal disease models, drug discovery, 
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neurobiology [34, 35], cell signalling [36-38] and observation of biochemical changes [37, 39, 
40]. 
Chronic and genotoxic effects of the nanomaterials have also been widely studied [41-50]. The 
Ames assay has been employed to observe Gene mutations in Chinese hamster lung (CHL/IU) 
cells upon exposure to fullerenes [51]. The combination of Ames test, micronuclei assay and 
comet assay have been used to demonstrate the effect of silver nanoparticles on Chinese 
hamster ovary cells [52]. HPLC and immunohistological techniques were employed to observe 
DNA base modifications on the basis of measurement of oxidized guanine upon silica 
nanoparticle exposure of the human adenocarcinoma cell line (A549) [53]. The comet assay 
has been used to identify single DNA strand breaks [48]. Northern blot analysis and PCR is 
widely employed to observe changes in the gene expression [54, 55]. 
Although conventional techniques have provided invaluable information regarding the 
interaction of nanomaterials with living systems, they remain limited in various aspects, such 
as the requirement of multiple labels and assays, interference of nanomaterials with the assay 
dyes [29, 56, 57], cost and also time required for the investigation.  
Cytotoxicity assays are based on measurement of a biomarker, or so-called ‘endpoint’, which 
usually has a fluorescent property and corresponds to a specific change to the state of the whole 
cell population [58]. Specificity of the ‘endpoints’ to a single type of toxicological event, within 
the cascade of events occurring upon toxicant exposure, results in inconsistencies of results 
obtained from different assays. Moreover, the nanomaterials can interfere with some of these 
assays. Carbon Nanotubes have been shown to interfere with the MTT and LDH assays, 
resulting in misleading results [29, 56, 57]. For the visualisation of the cells, optical microscopy 
remains limited due to its limited spatial resolution. Even though EM provides very detailed 
information, some nanomaterials do not provide the contrast and are therefore invisible within 
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the cellular environment [28, 59]. CLSM has invaluable advantages for visualisation of the 
nanomaterials within the cell, although the low resolution of fluorescent based techniques 
limits its potential. Also, some nanomaterials cannot be functionalised with dyes and the dye 
can leak to the environment which reduces the reliability of the results [60, 61]. HCS suffers 
from the disadvantages of the use of fluorescent dyes and specific‘endpoints’. The cost, 
problems in data management, lack of common standards are also limits in the use of HCS 
[39]. 
. 
3. Raman Microspectroscopy; towards High Content Nanotoxicological Assessment 
3.1. Raman Spectroscopy 
Although the Raman-effect was first demonstrated by Sir C. V. Raman and K. S. Krishnan in 
1928 [62], the developments in high powered light sources such as ion lasers widened the 
applications of Raman spectroscopy in the late 1960’s. The developments in Charged Coupled 
Detector (CCD) arrays, from the 1980’s onwards, added benefits to the high laser source 
intensities, the significant reductions in acquisition time with multichannel signal detection 
enabling and significant improvements are achieved in signal to noise ratio [63]. In addition, 
the development of narrow band laser line rejection filters meant that the huge losses in signal 
from traditional triple monochomator systems could be overcome with the combination of a 
filter set and a single spectroscopic grating. Raman spectroscopy, as a vibrational spectroscopic 
technique, has now become a really powerful technique for the characterisation and 
identification of biomolecules and biomolecular species, due to the narrow spectral bandwidths 
and ease of sample preparation [64].  
The developing technology of Raman spectroscopy and high potential of the technique in 
different areas, from medicine to industry, has led to the development of variants of the Raman 
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spectroscopy technique itself, such as surface enhanced Raman spectroscopy (SERS) [65], tip 
enhanced Raman spectroscopy (TERS) [66] and coherent anti Stokes Raman spectroscopy 
(CARS) [67, 68]. These techniques enable Raman spectroscopy to be more sensitive, to 
perform molecule specific analysis with enhanced signal.  
The applicability of Raman microspectroscopy has been widely shown for the analysis of 
bodily fluids, tumour tissue margining and analysis of cells and cellular compartments [69-75]. 
Raman microspectroscopy has been employed to visualise cells as well as their sub-cellular 
organisation [73, 74, 76, 77]. The cellular structures have been identified by combining Raman 
spectroscopy with immunofluorescence imaging [78], which enabled label-free imaging of live 
cells. Raman spectroscopy has been also co-registered with fluorescence microscopy for 
cellular imaging [79]. The differing biochemical composition of nucleus, nucleolus and 
cytoplasm has also been identified in a completely label free manner, based on intrinsic features 
of biochemicals [73, 80, 81]. The changes of the spectral signatures upon cell death have been 
shown by comparing spectral features of dead and live cells [82]. The importance of the use of 
multivariate analysis techniques such as Spectral Cross Correlation (SCC) and Classical Least 
Squares (CLS) analysis to extract information from huge Raman data sets has also shown by 
Keating et al. [76]. Raman spectral phenotyping with the aid of Principal Component Analysis 
(PCA) has also been studied by comparison of primary cells with cell line models [83]. 
Furthermore, as a label-free vibrational spectroscopic technique, both Infrared absorption (IR) 
and Raman spectroscopy have been employed for the localisation of nanomaterials inside the 
cell [77, 84-86]. Although IR analysis is challenged by the strong contributions of water in 
biological samples [87], Raman microspectroscopy is not affected to the same degree and has 
attracted attention for the analysis of biological samples [88]. Raman microspectroscopy also 
provides higher intrinsic spatial resolution for subcellular imaging compared to IR [89]. 
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The correlation between Raman spectral markers of carbon nanotubes (CNTs) and commonly 
used cytotoxicity assays has been studied by Knief et al. [90]. The studies of Dorney et al. [73] 
and Keating et al. [76] have shown the localisation of nanoparticles in cells and the use of 
multivariate analysis techniques to obtain more detailed information regarding to subcellular 
environment. Confocal Raman microspectroscopy has been employed to study the uptake and 
localisation of surface engineered CNTs, aluminium oxide and cerium dioxide nanoparticlesat 
single cell level in HepG2 liver cells [91]. The stress effects of silver nanoparticles as a funtion 
of applied concentration on human mesenchymal stem cells (hMSCs) has also been studied 
[92]. Uptake of titania and iron oxide nanoparticles into the nucleus of epithelial cells have 
been shown using Raman imaging with the aid of multivariate classification [93]. 
Although there has been huge effort and on-going research in the use of Raman 
microspectroscopy to explore the cellular interactions of nanomaterials, the studies have been 
somewhat fragmented and a systematic study of cell-nanoparticle interaction as a function of 
dose and time has not as yet been reported. 
This study aims to aggregate the results of recent studies [46, 50, 74, 94, 95] using Raman 
microspectroscopic analysis of nanoparticle exposure of cells in vitro, considering cell-
nanoparticle localisation, spectral marker identification as a function of time and dose, and 
consistency of the method in different cell lines and for different nanoparticles, with a view 
towards cohesively assessing its potential as a non-invasive, label-free and High Content 
Nanotoxicological Screening technique. For specific details of experimental protocols and data 
processing, the reader is referred to the publications describing the original studies. 
In order to establish a toxicological assessment protocol based on Raman microspectroscopy, 
a progressive and congregate route is followed, from nanoparticle localisation to modelling of 
3D plots based on spectral markers of toxicity which will ultimately allow the prediction of 
toxicity. Different commercially available nanoparticles are used as models throughout the 
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study. 40 nm non-toxic carboxyl-modified polystyrene nanoparticles (PSNPs) are employed to 
determine nanoparticle localisation and trafficking, whereas 100 nm toxic amine-modified 
polystyrene nanoparticles (PS-NH2) are used to determine spectral markers of the toxicity. 
Generation 5 PAMAM dendrimers are used as a secondary toxic nanoparticle model for 
comparison of spectral markers of toxicity. Moreover, the consistency of the spectral markers 
in different cell lines has been investigated using model cell lines for cancerous and non-
cancerous cells. Human adenocarcinoma cells (A549), human lung epidermoid (Calu 1) and 
human bronchial epithelium cell line (BEAS-2B) are chosen as model cell lines as they mimic 
one of the primary exposure route of nanomaterials, which is inhalation.  
3.2. Nanoparticle uptake and Trafficking  
Raman microspectroscopy has been employed to determine the localisation of non-toxic 
carboxylated polystyrene nanoparticles inside the cellular transport organelles, including early 
endosomes, lysosomes and endoplasmic reticulum, as a function of time following their uptake 
[74]. Confocal microscopy with different organelle staining was used to determine the 
localisation of nanoparticles from 4 to 24 h. Raman microspectroscopy was used to map the 
sub-cellular regions, at determined time points by confocal microscopy, to extract information 
regarding to nanoparticle localisation as nanoparticles are trafficked inside the cell.  
Due to the variability of surface properties and size of the nanomaterials, cell-nanomaterial 
interaction can occur in various ways. However, one of the primary uptake mechanisms of the 
nanoparticles is known to be endocytosis [96]. Although different mechanisms of endocytosis 
have been identified [97], endocytosis can be described as uptake of nanomaterials in 
membrane based vesicles. The confocal study showed the uptake mechanism of the 
carboxylated PSNPs by endocytosis and PSNPs are observed in early endosomes within 4 h. 
Then, PSNPs are carried to lysosomes which act as the digestion/recycling system of the cells 
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(12 h). After 12 h exposure of cells to the PSNPs, they are further trafficked to the endoplasmic 
reticulum, considered the final localisation point [74]. The Raman spectroscopic mapping of 
subcellular regions after 4, 12 and 24 h exposure to the PSNPs provided invaluable information 
regarding not only nanoparticle localisation but also identification of Raman signatures of 
organelles with the aid of multivariate analysis techniques. Early endosomes, lysosomes and 
endoplasmic reticulum are mainly composed of lipids which make them difficult to 
differentiate from each other. However, the study showed the potential of Raman 
microspectroscopy to differentiate organelle signatures based completely on their intrinsic 
biochemical properties in completely label-free manner. The differentiating spectral signatures 
are best viewed as the PCA loadings of 4, 12 and 24 h nanoparticle exposure data sets obtained 
from pairwise comparison of particle cluster and environment. Fig.1 shows varying the spectral 
signatures of endoplasmic reticulum, lysosome and endosomes after 4, 12 and 24 h carboxy-
PSNP exposure. The main differences on the spectral profiles of different organelles are 
highlighted with grey and some of the spectral markers are provided in Fig.1. 
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Fig.1 Comparison of PCA loadings of 4, 12 and 24 h nanoparticle exposure data sets. 
Loadings are offset for clarity. The dotted line represents the zero ‘0’ point for each loading 
and intensity scale of 0±0.1 is used for comparison. The figure is adapted from [74]. 
 
3.3. Acute toxicity of Nanoparticles 
3.3.1. Effects of Nanoparticles in Cytoplasm 
While carboxylated and neutral PS nanoparticles are known to be non-toxic, their aminated 
counterparts are known to show acute toxicity as a result of oxidative stress in the endosomal 
and lysosomal pathway [46, 73, 74,]. In order to observe acute toxicity and corresponding 
responses, time and dose dependant Raman spectroscopic markers of cellular toxic events were 
systematically monitored upon PS-NH2 and PAMAM exposure to cancerous and non-
cancerous cells [46, 50, 94, 95].  
Upon PS-NH2 exposure, the most dominant spectral marker is observed to be the ‘doublet 
band’ at 785 and 810 cm-1 in the cytoplasm, which indicates a change in the cytoplasmic RNA 
as a result of ROS formation and the doublet band is observed in particle exposed cells even at 
low doses (EC25) and short exposure times (after 4 h). The intensity of the band systematically 
and progressively changed as a function of dose and exposure time [46]. The doublet band was 
also observed in the biochemical features of Calu 1 cells following PS-NH2exposure and 
progressively changed with extended exposure times [50]. When, a second toxic nanoparticle 
model, PAMAM dendrimers, was introduced to the A549 cells, a similar trend to that for PS-
NH2 is observed for the double peak at 785 and 810 cm
-1, which, together, with the results 
obtained from different cell lines and nanoparticle models, validates the changes in cytoplasmic 
RNA to be a spectral marker of toxicity [94]. The changes in the doublet band, upon exposure 
to PS-NH2, are followed by concomitant and subsequent changes in the higher end of the 
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fingerprint which provides information about protein (Amide I region) and lipid damage (1229 
and 1438 cm-1). The band at 1438 cm-1, which has been identified upon PS-NH2 exposure, was 
also identified after exposure to PAMAM dendrimers and it has been observed to provide 
information regarding to lipotoxicity [46, 50, 94]. Therefore, it can be concluded that Raman 
spectroscopy identifies signatures of the initiating toxic response and following cellular 
dependant events, in real-time single assay and notably, brings new aspect to determination of 
nanomaterial toxicity by identifying cytoplasmic RNA as a spectral marker, which is not 
normally identified by conventional toxicity assays. Moreover, the doublet band can be seen 
as the first strong spectroscopic response of oxidative stress. Although, it does not measure the 
ROS directly, it provides information about the response, which is a ROS related change in 
cytoplasmic RNA. The onset of ROS formation upon nanoparticle exposure has been observed 
to be within 2-6 h [98, 99], and this initial stage of ROS dies away due to the action of 
intracellular antioxidants with a similar timescale [98]. In contrast, the doublet band is observed 
only after 8 h exposure to PS-NH2 and increases further with exposure time. Fig.2 shows the 
loadings of PCA obtained from pairwise comparison of particle exposed cells (24 h) and 
corresponding controls. Positive and negative features of the loadings relate to exposed and 
unexposed cells, relatively and the figure summarises spectral markers of acute toxic response 
in the cytoplasm, identified by Raman microspectroscopy.  
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Fig.2 Spectral Markers of acute toxic response in the cytoplasm of A549 and Calu 1 cells 
after 24 h exposure to PS-NH2 and PAMAM nanoparticles. Positive and negative features of 
the loadings relate to exposed and unexposed cells, relatively. The 750-830 cm-1 and above 
1000 cm-1 region are indicated with highlights. Loadings are offset for clarity. The dotted line 
represents the zero ‘0’ point for each loading and intensity scale of 0±0.05 is used for 
comparison [46, 50, 94]. 
 
The potential of Raman microspectroscopy as a single label-free technique with multi-
parametric information was further analysed by focusing on the validation of the technique by 
comparing spectral marker evolution in non-cancerous cells lines with cancerous cell lines [50] 
to build a ‘high content’ and ‘label-free’ Nanotoxicological assessment protocol. The spectral 
markers of toxic events such as oxidative stress and lysosomal damage have been identified as 
a function of time and the study showed that the identified spectral markers for cellular 
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dependant events show consistency across multiple cell lines which allow the identification of 
mechanism of action of the nanomaterial. The findings from the comparison of presence and 
progression of spectral markers, especially in low wavenumber region, have also shown the 
applicability of Raman spectroscopy to identify different cell death pathways in cancerous and 
non-cancerous cell lines (Fig.3) [50], Positive and negative features of the loadings relate to 
exposed and unexposed cells, relatively. The study showed the potential of Raman 
spectroscopy to provide further information regarding the mechanism of action as a single label 
free assay, without use of multiple labels and assays. 
 
 
Fig.3 Spectral markers of cell death on cancerous (A) and non-cancerous (B) cell lines and 
cytotoxicity assays which are found to be related the changes on these spectral markers. 
Loadings are offset for clarity. The dotted line represents the zero ‘0’ point for each loading 
and intensity scale of 0±0.05 is used for comparison. The figure is reproduced from the study 
of Efeoglu et al. [50]. 
 
3.3.2. Effects of Nanoparticles in the Nucleus and Nucleolus 
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Another notable outcome from the study has been determined to be the genotoxicity spectral 
markers. The spectral features of the nucleus and nucleolus showed significant changes as a 
function of time and dose upon PAMAM exposure. Nanoparticles such as PAMAM dendrimers 
are not fluorescent and do not provide contrast for EM studies, which makes cellular interaction 
studies challenging. Moreover, the small size of these dendrimers (~ 2-10 nm, depending on 
dendrimer generation) [100] makes them unsuitable for fluorescent labelling, which 
significantly changes their size and potentially their toxic properties. However, the use of 
Raman spectroscopy and systematic changes to the spectral signatures of biochemical 
composition of the cells can be used to elucidate their interaction with DNA and RNA inside 
the nucleus. The spectral range from 750 to 830 cm-1 is particularly useful to represent the 
mechanism of action of small non-fluorescent nanomaterials in nucleus and nucleolus. By 
comparison of PAMAM/DNA and PAMAM/RNA interactions, possible final localisation in 
the cells has been identified as the nucleolus which is not possible to observe with other current 
techniques. Spectral signatures of the post-translational modifications and corresponding 
biochemical changes, information which normally requires the use of multiple assays, have 
also been identified. 
The high degree of consistency upon exposure to different toxicants indicates a promising 
future for the use of those spectral markers identified by Raman microspectroscopy in 
nanotoxicology and nanomedicine. Based on the similar trends for the toxicity of different 
nanoparticles, the evolution of the spectral markers was further investigated to identify 
common and/or differing spectral markers of toxicity [95]. The findings of the study showed 
that, although spectral markers of cytoplasmic RNA, lipid and protein damage show 
consistencies, their evolutions show differences as a result of different response rates. 
Therefore, it can be concluded that Raman spectroscopy can give not only multi-parametric 
information based on intrinsic features of biochemicals upon toxicant exposure but also their 
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response rates. Notably, in this study, especially at extended exposure times, a significantly 
different evolution of spectral markers has been observed for the two different types of toxic 
nanoparticles, which can be attributed to different cell death mechanisms. Although the 
changes were more significant at long exposure times, the different response rates of the bands 
at early time points also provided information regarding the different cell death mechanisms. 
Cell death upon toxicant exposure can occur in multiple ways, most notably apoptosis and 
necrosis. The conventional apoptosis/necrosis assays use colorimetric identification based on 
cellular uptake of dyes and give information related to whether apoptotic or necrotic cell death 
has occurred. However, Raman microscopy not only provides information regarding whether 
the cell is apoptotic or necrotic, but also the biochemical path leading to this differentiation 
(Fig.4).  
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Fig.4 Spectral marker profiles of apoptotic and necrotic cell death. Comparison of Band 
intensities of 1003 (Phenlyalanine) (A) and 1438 (Lipids) (B) cm-1 bands calculated from 
PC1 from pairwise PCA of nucleus of exposed cells and corresponding control. Comparison 
of PC1 obtained from pairwise PCA of nucleus of exposed cells and corresponding control 
for 4, 8, 24, 48 and 72 h PAMAM-G5 (C) and PS-NH2 (D) exposure. The changes in the 
band intensities for PS-NH2 and PAMAM-G5 exposure are indicated with blue and red lines, 
respectively. Data are expressed as % of control mean ± SD. The negative side of the loading 
represents the spectral features of control, whereas positive side represents the cells exposed 
to PS-NH2 and PAMAM-G5. Loadings are offset for clarity. The dotted line represents the 
zero ‘0’ point for each loading and intensity scale of 0±0.05 is used for comparison [46, 50, 
94, 95]. 
Adopting the terminology of the Adverse Outcome Pathway methodology [101], upon 
exposure to a toxicant, the response begins with a molecular initiating event (MIE) which 
induces a cascade of consequent events. In the current context, the MIE is identified as the 
initial oxidative stress caused by the ingestion of the nanoparticles in exosomes and ultimately 
results in a change in cytoplasmic RNA, manifest as changes in the doublet peak of 785 cm-1 
and 810cm-1. The study of Maher et al.[102] showed that the MIE shows particle dependency 
and induces cellular dependant events which can include, for example, changes in 
mitochondrial function, activation of caspases, and release of inflammatory factors. However, 
conventional and commonly used cytotoxicity assays use specific markers which can be 
defined as ‘endpoints’ and identify the toxicity as a function of half-maximal effective dose 
‘EC50’. Therefore, these assays remain limited to provide information regarding to multiple 
events that occur concomitantly or consecutively inside the cell. Raman microspectroscopy 
shows signatures of this cascade as presence of spectral markers of initiating toxic event at low 
doses and short exposure times in low wavenumber region (cytoplasmic RNA, indirect ROS), 
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followed by concomitant changes (Protein and lipid damage as a result of cellular toxic events) 
in high wavenumber region of fingerprint. 
 
3.4. 3D Toxic Response to Nanoparticles Determined by Raman Microspectroscopy 
A notable finding from the studies based on comparison of the spectral profiles was the 3D 
dimensional correlation of the spectral markers. The 3D response surface of cytotoxicity has 
previously been highlighted [102], whereby similar responses are elicited when cells are 
exposed to higher concentrations of a toxicant for short exposure time and low concentrations 
for longer exposure times. This 3D relationship is also evident in the time and dose 
dependences of the spectral markers identified by Raman microspectroscopy. Fig.5 shows the 
loadings of PC1 obtained from pairwise comparison of cytoplasm of particle exposed cells with 
their corresponding controls. The positive features represent the biochemical composition of 
the particle exposed cells, whereas negative features represent the composition of control cells. 
As seen in Fig.5(A), the loadings of the PCA from the cytoplasm of PS-NH2 exposed cells 
show similar trends when cells are exposed to 10 µM (lethal dose) of PS-NH2 for 8 h and 2.5 
µM (sublethal dose) for 48 h. Moreover, the 3D response effect is observed for PAMAM 
dendrimers even between sublethal doses and the loadings showed similar features when the 
cells are exposed to EC10 for 24 h and EC25 for 8 h (Fig.5(B)).  
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Fig.5 Comparisons of the loading 1 of PCA of cytoplasm for exposed and control cells. (A) 
After 8 h exposure to 10 μM (red) and 48 h 2.5 μM (blue) PS-NH2. (B) After 8 h exposure to 
EC25 (red) and 24 h EC10 μM (blue) PAMAM dendrimers. Positive and negative features of 
the loadings relate to exposed and control cells, relatively. The areas that show similar 
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responses are indicated with highlights. Loadings are offset for clarity. The dotted line 
represents the zero ‘0’ point for each loading and intensity scale of 0±005 is used for 
comparison [46, 94]. 
The 3D response has also been monitored within the nuclear region (nucleus and nucleolus) 
for cells exposed to PAMAM dendrimers, as seen in Fig.6. The spectral markers of 
genotoxicity, at 750-830 cm-1, showed similar patterns when cells are exposed to EC10 for 24 
h and EC25 for 8 h. 
21 
 
 
Fig.6 Comparison of the loading 1 of PCs of nucleus and nucleolus for exposed and 
unexposed cells after 8 h exposure to EC25 (red) and 24 h EC10 (blue) PAMAM dendrimers. 
Positive and negative features of the loadings relate to exposed and unexposed cells, 
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relatively. The 750-830 cm-1 area is indicated with highlights. Loadings are offset for clarity. 
The dotted line represents the zero ‘0’ point for each loading and intensity scale of 0±0.05 is 
used for comparison [94]. 
 
The 3D toxic responses, which are observed based on identified spectral markers of the toxicity 
can be represented in 3D plots of Spectral Marker intensities which can be used for the 
prediction of toxic events of any nanomaterial by observation of the spectral markers. As an 
example, the Raman spectral data sets for PAMAM dendrimers as a function of time and dose 
are used as an input to build 3D plots. The four main spectral markers which have been 
identified throughout the study, 785, 810, 1003 and 1438 cm-1, are simultaneously plotted 
against time point and dose. The band intensities of the identified markers have been observed 
to change as a function of dose and time, which is manifest as an increase in the positive 
features, or inversion to negative features, of the loading of the PCA. The increase of the 
intensity of positive features can be attributed to an increase, accumulation and/or a 
conformational change of the biochemical constituent, whereas inversion to the negative 
features indicates damage and loss of the constituent upon exposure, in both cases compared 
to unexposed control. Fig.7 shows the representative 3D mesh and contour plot created to show 
spectral marker intensity distribution of the 785 and 810 cm-1 in the cytoplasm as a function of 
time and dose of PAMAM G5 exposure. A colour scale is provided to show intensity of the 
spectral marker for contour plots. In the 3D plots based on spectral marker intensities, a range 
of areas from safe to toxic can be identified and the plots can be further applied to different 
nanoparticles and pharmaceuticals to identify the range they fit into. The 785 and 810 cm-1 
spectral marker was identified as one of the most significant markers observed throughout the 
study, showing dramatic and progressive changes as a function of dose and exposure times. 
The band at 785 cm-1 (nucleic acid) showed a progressive decrease with increasing dose, 
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whereas an increase followed by decrease is observed with extended exposure times (Fig.7(A)). 
When the intensity of the spectral marker band at 785 cm-1 is correlated with 24 h cellular 
%viability determined by AB assay as EC10, EC25, EC50 and EC75, a significant correlation is 
observed and the intensity of the marker is reduced with reducing viability. The approximate 
viability values obtained from EC50 curve fits after 24 h exposure are presented in Fig.7(B) in 
white text. The origin of the 810 cm-1 band has been identified as changes in cytoplasmic RNA 
as a result of formation of ROS. The intensity reaches its highest value at ~24-48 h, after which 
a significant loss of the signature of cytoplasmic RNA can be observed (Fig.7(C and D). 
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Fig.7 3D mesh and contour plot of 785 (A, B) and 810 cm-1 (C, D) spectral marker intensity 
as a function of time (h) and dose (ECn). The 24 h cellular viability at EC10, EC25, EC50 and 
EC75 determined by AB assay are indicated with percentages on the plot (white). 
 
However, this relation is not observed for the band at 810 cm-1 spectral marker. The different 
dose/time dependencies of the spectral markers can be related to consecutive cascade of events 
occurring within the cell upon a toxicant exposure. The band at 786 cm-1 originates from the 
ring breathing modes of nucleic acid bases (U, T and C) and also from O-P-O backbone. 
Therefore, the presence of the band in the features of the loadings can be attributed to nucleic 
acids, RNA and/or DNA [82, 103, 104]. On the other hand, the band at 810 cm-1 is known to 
be more specific to sugar-phosphate diester of RNA [105, 106]. The cytoplasmic RNA 
significantly gets affected by oxidative stress and increased ROS levels results repression of 
translation and accumulation of non-coding RNAs. A concomitant increase in the 785 cm-1 
band can also be observed in short exposure times. A secondary increase in 785 cm-1 band, 
which evolves different, compared to 810 cm-1 band can be attributed to independent toxic 
event in the cell.  
Notably, time evolution of the ROS dependant cytoplasmic RNA band (810 cm-1) show 
significant differences to the simulation models of Maher et al. [102] (Fig.8). When the 
simulated cytotoxic (A) and spectroscopic data (B) are analysed, while similar patterns are 
observed, the evolution occurs over different timescale, which can be related to the formation 
of ROS as an initiating toxic event followed by changes in cytoplasmic RNA at later times, as 
response to ROS formation. However, due to the lack of data in our experimental model, the 
plots remained limited to show time related pattern in extended exposure times.  
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Fig.8 3D mesh plots representing the response of (A) Simulated model of Reactive oxygen 
species (B) 810 cm-1 spectral marker intensity. (A) is adapted from Maher et al.[102] 
 
The 1003 cm-1 (protein) and 1438 cm-1 (lipotoxicity) spectral markers have been also plotted 
in the same format and are shown in Fig.9. The 3D plots show consistency with the 785 cm-1 
spectral marker in terms of cellular viability. After 24 h exposure, with increasing dose, cellular 
viability is decreased with concomitant decrease in the intensity of the bands. Especially, at 
longer time points, the graphs remained limited due to lack of data. 
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Fig.9 3D mesh and contour plot 1003 (A and B) and 1438 (C and D) cm-1 spectral marker 
intensity as a function of time and dose. The cellular viability at EC10, EC25, EC50 and EC75 
are indicated with percentages on the plot (white). 
 
4. Future perspectives 
The established 3D plots help to illustrate the potential of Raman microspectroscopy as a ‘High 
Content Nanotoxicological Screening technique’, which can be used to determine and predict 
Nanotoxicity based on spectral intensities. Although the plots are created for PAMAM 
dendrimers, the markers are derived from intrinsic properties of biochemical constituents of 
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the cells which are related to individual cellular events and the plots can be applied to a wide 
range of nanomaterials and potentially even to the pharmaceuticals. 
Further refinements on the development of the plots can be achieved by the use of multiple 
time points and doses. With improved sensitivities of Raman microspectrometers, or through 
CARS and SRS techniques, real-time live cell monitoring can potentially be achieved. 
Moreover, the use of more sophisticated and quantitative multivariate techniques, such as 
Partial Least Squares Regression (PLSR) and Multivariate Curve Resolution Alternating Least 
Squares (MCR-ALS), for analysis of Raman spectral data sets for the identification of spectral 
marker intensities can enable the establishment of improved 3D plots.  
Nanocarrier systems for drug delivery applications has attracted a significant attention to achieve targeted 
delivery of drugs in area of interest and to develop personalized medicine [107-111]. The identified spectral 
markers and spectral features of Raman active nanocarriers can further be utilized to track the localization 
of the nanocarriers within a cell, as well as to monitir responses produced in cells upon release of drug from 
carriers. Notably, the nanocarriers are localised within the cell, initially in endosomes, and can be 
subsequently trafficked to lysosomes and, for example the endoplasmic reticulum, and the local environment 
of the nanoparticles and therefore the encapsulating vesicle can also be characterised by Raman 
microspectroscopic mapping [74]. In the case where random points in the cytoplasm or nucleus are recorded, 
at least at low to moderate doses, little or no contribution of the nanoparticles or their encapsulating 
environment is observed, and the recorded responses are primarily due to the cellular responses. 
 
5. Conclusion 
The work presented in this study has demonstrated the potential of Raman microspectroscopy 
as a label free high content toxicological screening technique which can utilized for the rapid 
advances in nanotoxicology and nanomedicine and investigation of wide range of 
nanomaterials real-time in a rapid, label-free way. The use of Raman microspectroscopy as a 
toxicological assessment protocol can provide many advantages over current techniques by 
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using intrinsic features of biomaterials. The technique provides a multifaceted data which gives 
information about localisation and trafficking, cellular viability, mechanism of interaction, 
response rates and cell death mechanism as well as pathways leading to cell death. Continued 
development of instrumental technologies, and the emergence of nonlinear Raman techniques, 
promise real time, live cell monitoring of nanoparticle uptake and cellular response, for which 
more sophisticated, multivariate analysis and data-mining techniques will be required. 
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